抑癌基因抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 抑癌基因抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

DMBT 1 may play roles in mucosal defense system, cellular immune defense and epithelial differentiation. May play a role in liver regeneration. May be an important factor in fate decision and differentiation of transit-amplifying ductular(oval) cells within the hepatic lineage.抑癌基因抗体 May function as a binding protein in saliva for the regulation of taste sensation. May play a role as an opsonin receptor for SFTPD and SPAR in macrophages tissues throughout the body, including epithelial cells lining the gastrointestinal tract. Required for terminal differentiation of columnar epithelial cells during early embryogenesis. [Subcellular Location] Secreted.抑癌基因抗体 Membrane. [Tissue Specificity] Expressed in von Ebner glands (VEG) (at protein level), olfactory epithelium and the lateral nasal gland. Expressed in transit-amplifying ductular (oval) cells. Up-regulated at day 3 after hepatectomy. Expressed in newly formed bile ducts and in structures resembling intestinal epithelium. Belongs to the DMBT1 family.

Also known as:

抑癌基因抗体DMBT1; Apactin; CRP; CRP-[a]; CRP-[b]; CRP-ductin; Crpd; DBMT1; Deleted in malignant brain tumors 1; Deleted in malignant brain tumors 1 protein; DMBT 1; DMBT1; DMBT1 prototype precursor; DMBT1/6kb.1 protein precursor; DMBT1/8kb.1 protein; DMBT1/8kb.2 protein precursor; Ebnerin; Glycoprotein 300; Glycoprotein 340; Gp 340; gp300; Gp340 variant protein; Hensin; Mucin-like glycoprotein; Muclin; p80; Pancrin; Salivary agglutinin; Surfactant pulmonary associated D binding protein; Surfactant pulmonary associated protein D binding protein; Vomeroglandin.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, .

●

Immunogen: KLH conjugated synthetic peptide derived from human DMBT1.

●

抑癌基因抗体Predicted Molecular Weight: 156-265kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl675Ra01凝血因子Ⅴ(F5)多克隆抗体Polyclonal Antibody to Coagulation Factor V (F5)

kl677Hu01凝血因子Ⅻ(F12)多克隆抗体Polyclonal Antibody to Coagulation Factor XII (F12)

kl677Mu01凝血因子Ⅻ(F12)多克隆抗体Polyclonal Antibody to Coagulation Factor XII (F12)

kl680Hu01棕榈酰化膜蛋白2(MPP2)多克隆抗体Polyclonal Antibody to Membrane Protein, klmitoylated 2 (MPP2)

kl680Ra01棕榈酰化膜蛋白2(MPP2)多克隆抗体Polyclonal Antibody to Membrane Protein, klmitoylated 2 (MPP2)

kl681Hu01乙醇脱氢酶1(ADH1)多克隆抗体Polyclonal Antibody to Alcohol Dehydrogenase 1 (ADH1)

kl681Mu01乙醇脱氢酶1(ADH1)多克隆抗体Polyclonal Antibody to Alcohol Dehydrogenase 1 (ADH1)

kl681Ra01乙醇脱氢酶1(ADH1)多克隆抗体Polyclonal Antibody to Alcohol Dehydrogenase 1 (ADH1)

kl683Hu01Toll样受体6(TLR6)多克隆抗体Polyclonal Antibody to Toll Like Receptor 6 (TLR6)

kl685Hu01CD14分子(CD14)多克隆抗体Polyclonal Antibody to Cluster Of Differentiation 14 (CD14)

kl685Ra01CD14分子(CD14)多克隆抗体Polyclonal Antibody to Cluster Of Differentiation 14 (CD14)

kl687Hu01钙结合蛋白(CR)多克隆抗体Polyclonal Antibody to Calretinin (CR)

kl688Hu01TGFβ诱导早期应答基因1(TIEG1)多克隆抗体Polyclonal Antibody to TGF Beta Inducible Early Response Gene 1 (TIEG1)

kl690Hu01激肽释放酶8(KLK8)多克隆抗体Polyclonal Antibody to Kallikrein 8 (KLK8)

kl691Hu01激肽释放酶6(KLK6)多克隆抗体Polyclonal Antibody to Kallikrein 6 (KLK6)

kl691Ra01激肽释放酶6(KLK6)多克隆抗体Polyclonal Antibody to Kallikrein 6 (KLK6)